We use cookies to provide you a better experience. By continuing to use this website, you consent to the use of cookies in accordance with our Cookie Policy.

Hervé Ronin

Managing Director

Paris

herve.ronin@stifel.com | v-Card

Herve is Managing Director in the Healthcare Group based in Paris and joined Stifel in 2025 through the acquisition of Bryan, Garnier & Co where he was a Partner and Head of the firm’s Healthcare
Investment Banking Team . He has over 25 years of corporate finance experience, having successfully advised on M&A and ECM transactions across all healthcare segments

He previously held positions at BNP Paribas Corporate Finance and contributed to the creation and development of Sanofi. His recent deals include the acquisition of IPRAD by Biocodex and Genfit’s
NASDAQ IPO.

Herve graduated from ESSEC Business School.

In the United States, this site is published in the United States for U.S. residents only. The information on this web site is not an offer to sell or a solicitation of an offer to buy any security, nor shall any such security be offered or sold to any person in any jurisdiction in which such offer, solicitation, purchase, or sale may not lawfully be made. Stifel Financial Advisors may only conduct business with residents of the states in which they are properly registered. References to Stifel herein may apply to parent company Stifel Financial Corp. or any of its wholly owned subsidiaries, including Stifel, Nicolaus & Company, Incorporated, Member NYSE, FINRA, and SIPC. Stifel Nicolaus Europe Limited is authorised and regulated by the Financial Conduct Authority.